News from NYU Langone Health
The Secret To Sticking With Exercise May Be As Simple As Asking Yourself These 5 Questions. (Women's Health)
(7/15) A new study published in Frontiers in Psychology suggests that aligning exercise routines with personality types may enhance motivation and enjoyment, with Thea Gallagher, PsyD, clinical associate professor, Department of Psychiatry, saying, “Just doing things because we know it’s good for us doesn’t tend to work out well,” and emphasizing the importance of joy in sustaining workout routines; the study involved 132 participants and identified that traits like extraversion and neuroticism influence exercise preferences, potentially guiding personalized exercise programs to improve adherence and satisfaction.
15 ASC, Physician Deals To Know In 2025. (Becker's ASC Review)
(7/15) A listicle of “15 major sales of ASCs, physician practices and clinics so far in 2025” included that “New York City-based NYU Langone Health and NYU Langone Orthopedics announced the acquisition of Rothman Orthopaedics of Greater New York, and in New York City, which expanded the system’s orthopedic care in the city.”
Top Orthopedic Residency Programs In 2025: Doximity. (Becker's Orthopedic & Spine Review)
(7/15) NYU Grossman School of Medicine and NYU Orthopedic Hospital has been named one of Doximity’s 2025-2026 Residency Navigator’s top orthopedic residency programs,
NYU Langone Health Moving Ahead With Planned $38M Ambulatory Surgery Center In West Harrison. (Fairfield County (CT) Business Journal)
The (7/15) NYU Langone Health has proposed a plan to establish an Ambulatory Surgery Center for orthopedic services at 4 Westchester Park Drive in West Harrison, estimating a project cost of $38,435,000, with $7,770,000 allocated for facility equipment; the center will initially employ 47 staff members, expanding to 65 by its third year, and will include four operating rooms, a pre-procedure preparation and post-surgery recovery area with 12 bays, and a multipurpose room for examinations and consultations, while functioning under the oversight of NYU Langone Health for quality assurance, credentialing, and utilization monitoring, according to its Certificate of Need filing with the New York State Department of Health.
Sarilumab Plus Ipilimumab, Nivolumab, And Relatlimab Displays High Response Rate In Unresectable Melanoma. (OncLive)
(7/15) During the 2025 ASCO Annual Meeting, a phase 2 study presented results showing that the combination of sarilumab (Kevzara), ipilimumab (Yervoy), nivolumab, and relatlimab-rmbw (Opdualag) was effective and safe for patients with unresectable stage III or IV melanoma, achieving a 24-week overall response rate of 63.6% with no grade 5 toxicities Janice Mehnert, MD, professor, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter 鶹Ƶapp Center, said, “We’re seeing an interesting signal that by adding IL-6 inhibition we don’t sacrifice anything in terms of response.”
Lupita Nyong’o Rejects ‘The Normalization Of Female Pain’ While Sharing Her Experience With Fibroids. (The Grio)
(7/15) Actress Lupita Nyong’o shared her personal experience with uterine fibroids on Instagram during Fibroid Awareness Month, revealing her struggle with the condition since 2014, when she had surgery to remove 30 fibroids and was told by her physician that recurrence was inevitable; she advocates for better education, screening, and treatment options, and highlighted tennis star Venus Williams’ similar experience, which led to her seeking care at the NYU Langone Health’s Center for Fibroid Care, while Nyong’o also announced her involvement with legislators on bills to enhance fibroid research and awareness, and her partnership with the Foundation for Women’s Health to fund research on less invasive treatments.
Also reporting is (7/15).
16 Best Hyaluronic Acid Serums And Creams Of 2025. (NBC News)
(7/15) Mary L. Stevenson, MD, associate professor, the Ronald O. Perelman Department of Dermatology, highlights hyaluronic acid’s ability to hydrate all skin types by absorbing moisture, noting its unique properties compared to other acids and saying, “It’s not like salicylic acid or some of the other acids that can be more exfoliating or abrasive on our skin.”
This Woman Started Taking A Supplement. It Nearly Killed Her Liver. (Staten Island (NY) Advance)
(7/15) that Katie Mohan, 57, of Morristown, N.J., experienced acute liver damage after taking Youtheory turmeric pills purchased from Costco, requiring treatment at NYU Langone Health from Nikolaos Pyrsopoulos, MD, MBA, PhD, clinical professor, Department of Medicine, Division of Gastroenterology and Hepatology, Transplant Institute, who confirmed, “Her liver numbers were 60 to 70 times above the normal limit,” adding “she was very yellow.”
Also reporting was (7/16).
76ers’ Paul George Undergoes Surgery For Off-Season Knee Injury. (UPI)
UPI (7/15) Philadelphia 76ers forward Paul George underwent a successful arthroscopic knee surgery at the NYU Langone Health’s Sports Medicine Orthopedic Center, performed by Jonathan L. Glashow, MD, clinical associate professor, Department of Orthopedic Surgery, following an off-season injury.
Also reporting is Philadelphia (7/15).
Doctor Explains Vital Reason ‘Ozempic Sex’ Side Effect Happens To Those Using The Medication. (LADBible (UK))
(7/15) Rachel L. Goldman, PhD, clinical assistant professor, Department of Psychiatry, provided insights into how GLP-1 medications affect sexual drive, saying, “What we do know is GLP-1s impact the reward centre in the brain, which is why you’re having less food noise, fewer cravings and less interest in alcohol use,” noting it is “also why what might impact your sex drive.”
News from NYU Langone Hospital—Long Island
Be Well: What To Know About The Alarming Rise In Skin 鶹Ƶapp Rates For Women. (News 12-TV Long Island (NY))
Long Island, NY (7/15) Nicole M. Golbari, MD, MPH, clinical associate professor, Department of Medicine—Long Island and a skin cancer survivor, discussed the concerning increase in skin cancer rates among women of all skin tones and backgrounds, describing it as a growing public health issue.
